NCT05669105View on ClinicalTrials.gov

Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 19, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

March 31, 2024

Conditions
Non Small Cell Lung Cancer
Interventions
DIAGNOSTIC_TEST

Specimen sample

Participants will have up to 100 mL of whole blood collected.

Trial Locations (1)

02451

RECRUITING

Sanguine Biosciences, Waltham

Sponsors
All Listed Sponsors
lead

Sanguine Biosciences

INDUSTRY

NCT05669105 - Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research | Biotech Hunter | Biotech Hunter